Date: 18 September 2018
As we all know, Dosage Administration Aids (DAA’s) are an invaluable tool in medication management and should be embraced in modern pharmacy practice.
For the purposes of the 6CPA, a DAA is defined as ‘a well-sealed, tamper-evident device that allows individual medicine doses to be organised according to the prescribed dose schedule.’
Pharmacists can be remunerated $6.08 by the 6CPA per patient each week for the supply of DAAs to eligible community patients. Amongst other conditions, eligible patients must hold a concession and Medicare card, and the numbers are capped.
Residential care facilities are the highest users of DAAs to maintain patient medication safety and compliance. Supply of DAAs to care facilities does not attract federal funding for the pharmacy.
However, the pharmacy owner is able to negotiate a fee for preparation and supply of DAAs to patients.
Sounds great, doesn’t it?
More patients, more scripts, more turnover, more revenue!
Maybe even more accompanying retail sales!
But unfortunately, there are some financial and logistical considerations when taking on more DAAs. In fact, using some basic assumptions, the true cost of a DAA can be around $18.
Most importantly, consider the time and effort required by you and your pharmacists. Do the sums and be sure this is the best use of resources. Are you taking a pharmacist away from a customer facing role? How will this affect service levels in your pharmacy? Will OTC and retail sales suffer? Will your Professional Services Offer be impacted?
Customers like and appreciate time spent with them by the pharmacist. Optimum pharmacist contact with your customers is vital to enhance the Customer Experience.
|DAA - Materials||$1.50|
|DAA - 30 Min Tech||$10.00|
|DAA - 10 Min Pharmacist||$6.65|
|DAA - Total Cost||$18.15|
|AHI + Dispensary Fee||$8.32|
$15.75 loss per patient per week
$819.00 loss per patient per year
$40 950 loss per per year per 50 patients
Contact: Andria Aird
Phone: 08 9429 4100
There are currently no comments on this post.